GPP can be triggered by the initiation and withdrawal of various medications, in particular the withdrawal of corticosteroids, and by infections, stress, and other conditions. 1,5,6,10 Patients with a ...
BRACKNELL, England--(BUSINESS WIRE)--Boehringer Ingelheim announced today the publication in the New England Journal of Medicine of new data from the pivotal Phase II Effisayil TM 1 trial, which ...
What Is Generalized Pustular Psoriasis? Generalized pustular psoriasis (GPP) is the rarest form of psoriasis, a chronic autoimmune skin condition. GPP can be severe, even life-threatening. The disease ...
New top-line data from a global Phase 3 clinical trial of patients with generalized pustular psoriasis (GPP) flares show rapid clearance of pustulation, erythema and scaling through four weeks after a ...
An international consensus statement on generalized pustular psoriasis (GPP) from the International Psoriasis Council (IPC) includes the recommendation that considerations such as body surface area ...
Ryan Haumschild, PharmD, MS, MBA: Welcome to this AJMC ® [The American Journal of Managed Care ®] program titled, “Generalized Pustular Psoriasis: Provider and Payer Considerations for Care.” I am Dr ...
AnaptysBio Inc ANAB released topline results from its global Phase 3 GEMINI-1 trial of imsidolimab (IL-36R mAb) in patients with generalized pustular psoriasis (GPP) flares. During a GPP flare, ...
Everyday Health on MSN
Is that rash psoriasis, or is it something else?
From white blisters to red and scaly patches, psoriasis skin rashes come in several different forms. How do you know if you have psoriasis or a similar-looking skin condition?
A 5-day-old female is transferred from another hospital due to irritability and a worsening pustular rash. The mother’s pregnancy, labor and delivery was complicated by a group B strep-positive ...
The WHO declared monkeypox a public health emergency on Saturday. With the World Health Organization declaring monkeypox a public health emergency of international concern on Saturday, the United ...
New clinical trial data published today in the New England Journal of Medicine, showed that spesolimab, a novel IL-36R antibody treatment, was effective in rapidly treating adult patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback